Skip to main content
Erschienen in: Cancer Causes & Control 10/2016

12.08.2016 | Original paper

A prognostic model for advanced colorectal neoplasia recurrence

verfasst von: Lin Liu, Karen Messer, John A. Baron, David A. Lieberman, Elizabeth T. Jacobs, Amanda J. Cross, Gwen Murphy, Maria Elena Martinez, Samir Gupta

Erschienen in: Cancer Causes & Control | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Following colonoscopic polypectomy, US Multisociety Task Force (USMSTF) guidelines stratify patients based on risk of subsequent advanced neoplasia (AN) using number, size, and histology of resected polyps, but have only moderate sensitivity and specificity. We hypothesized that a state-of-the-art statistical prediction model might improve identification of patients at high risk of future AN and address these challenges.

Methods

Data were pooled from seven prospective studies which had follow-up ascertainment of metachronous AN within 3–5 years of baseline polypectomy (combined n = 8,228). Pooled data were randomly split into training (n = 5,483) and validation (n = 2,745) sets. A prognostic model was developed using best practices. Two risk cut-points were identified in the training data which achieved a 10 percentage point improvement in sensitivity and specificity, respectively, over current USMSTF guidelines. Clinical benefit of USMSTF versus model-based risk stratification was then estimated using validation data.

Results

The final model included polyp location, prior polyp history, patient age, and number, size and histology of resected polyps. The first risk cut-point improved sensitivity but with loss of specificity. The second risk cut-point improved specificity without loss of sensitivity (specificity 46.2 % model vs. 42.1 % guidelines, p < 0.001; sensitivity 75.8 % model vs. 74.0 % guidelines, p = 0.64). Estimated AUC was 65 % (95 % CI: 62–69 %).

Conclusion

This model-based approach allows flexibility in trading sensitivity and specificity, which can optimize colonoscopy over- versus underuse rates. Only modest improvements in prognostic power are possible using currently available clinical data. Research considering additional factors such as adenoma detection rate for risk prediction appears warranted.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR et al (2010) Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375:1624–1633CrossRefPubMed Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR et al (2010) Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375:1624–1633CrossRefPubMed
3.
Zurück zum Zitat Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA et al (2012) Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 143:844–857CrossRefPubMed Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA et al (2012) Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 143:844–857CrossRefPubMed
4.
Zurück zum Zitat Martínez ME, Ahnen D, Greenberg ER (2013) One-year risk for advanced colorectal neoplasia. Ann Intern Med 158:639CrossRefPubMed Martínez ME, Ahnen D, Greenberg ER (2013) One-year risk for advanced colorectal neoplasia. Ann Intern Med 158:639CrossRefPubMed
5.
Zurück zum Zitat Martínez ME, Baron JA, Lieberman DA, Schatzkin A, Lanza E et al (2009) A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroentereolgy 136:832–841CrossRef Martínez ME, Baron JA, Lieberman DA, Schatzkin A, Lanza E et al (2009) A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroentereolgy 136:832–841CrossRef
6.
Zurück zum Zitat Laiyemo AO, Murphy G, Albert PS, Sansbury LB, Wang Z et al (2008) Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years. Ann Intern Med 148:419–426CrossRefPubMed Laiyemo AO, Murphy G, Albert PS, Sansbury LB, Wang Z et al (2008) Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years. Ann Intern Med 148:419–426CrossRefPubMed
7.
Zurück zum Zitat Pinsky PF, Schoen RE, Weissfeld JL, Church T, Yokochi LA et al (2009) The yield of surveillance colonoscopy by adenoma history and time to examination. Clin Gastroenterol Hepatol 7:86–92CrossRefPubMed Pinsky PF, Schoen RE, Weissfeld JL, Church T, Yokochi LA et al (2009) The yield of surveillance colonoscopy by adenoma history and time to examination. Clin Gastroenterol Hepatol 7:86–92CrossRefPubMed
8.
Zurück zum Zitat Chung SJ, Kim YS, Yang SY, Song JH, Kim D et al (2011) Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans. Gut 60:1537–1543CrossRefPubMed Chung SJ, Kim YS, Yang SY, Song JH, Kim D et al (2011) Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans. Gut 60:1537–1543CrossRefPubMed
9.
Zurück zum Zitat Stegeman I, de Wijkerslooth TR, Stoop EM, van Leerdam ME, Dekker E et al (2013) Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer. Cancer Epidemiol 37:278–283CrossRefPubMed Stegeman I, de Wijkerslooth TR, Stoop EM, van Leerdam ME, Dekker E et al (2013) Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer. Cancer Epidemiol 37:278–283CrossRefPubMed
10.
Zurück zum Zitat Saini SD, Kim HM, Schoenfeld P (2006) Incidence of advanced adenomas at surveillance colonoscopy in patients with a personal history of colon adenomas: a meta-analysis and systematic review. Gastrointest Endosc 64:614–626CrossRefPubMed Saini SD, Kim HM, Schoenfeld P (2006) Incidence of advanced adenomas at surveillance colonoscopy in patients with a personal history of colon adenomas: a meta-analysis and systematic review. Gastrointest Endosc 64:614–626CrossRefPubMed
11.
Zurück zum Zitat van Heijningen EM, Lansdorp-Vogelaar I, Kuipers EJ, Dekker E, Lesterhuis W et al (2013) Features of adenoma and colonoscopy associated with recurrent colorectal neoplasia based on a large community-based study. Gastroenterology 144:1410–1418CrossRefPubMed van Heijningen EM, Lansdorp-Vogelaar I, Kuipers EJ, Dekker E, Lesterhuis W et al (2013) Features of adenoma and colonoscopy associated with recurrent colorectal neoplasia based on a large community-based study. Gastroenterology 144:1410–1418CrossRefPubMed
12.
Zurück zum Zitat Laiyemo AO, Pinsky PF, Marcus PM, Lanza E, Cross AJ et al (2009) Utilization and yield of surveillance colonoscopy in the continued follow-up study of the polyp prevention trial. Clin Gastroenterol Hepatol 7:562–567CrossRefPubMed Laiyemo AO, Pinsky PF, Marcus PM, Lanza E, Cross AJ et al (2009) Utilization and yield of surveillance colonoscopy in the continued follow-up study of the polyp prevention trial. Clin Gastroenterol Hepatol 7:562–567CrossRefPubMed
13.
Zurück zum Zitat Schatzkin A, Lanza E, Corle D, Lance P, Iber F et al (2000) Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med 342:1149–1155CrossRefPubMed Schatzkin A, Lanza E, Corle D, Lance P, Iber F et al (2000) Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med 342:1149–1155CrossRefPubMed
14.
Zurück zum Zitat Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D et al (2003) A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348:891–899CrossRefPubMed Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D et al (2003) A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348:891–899CrossRefPubMed
15.
Zurück zum Zitat Alberts DS, Martínez ME, Roe DJ, Guillen-Rodriguez JM, Marshall JR et al (2000) Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians’ Network. N Engl J Med 342:1156–1162CrossRefPubMed Alberts DS, Martínez ME, Roe DJ, Guillen-Rodriguez JM, Marshall JR et al (2000) Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians’ Network. N Engl J Med 342:1156–1162CrossRefPubMed
16.
Zurück zum Zitat Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW et al (1999) Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 340:101–107CrossRefPubMed Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW et al (1999) Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 340:101–107CrossRefPubMed
17.
Zurück zum Zitat Greenberg ER, Baron JA, Tosteson TD, Freeman DH Jr, Beck GJ et al (1994) A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med 331:141–147CrossRefPubMed Greenberg ER, Baron JA, Tosteson TD, Freeman DH Jr, Beck GJ et al (1994) A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med 331:141–147CrossRefPubMed
18.
Zurück zum Zitat Alberts DS, Martínez ME, Hess LM, Einspahr JG, Green SB et al (2005) Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst 97:846–853CrossRefPubMed Alberts DS, Martínez ME, Hess LM, Einspahr JG, Green SB et al (2005) Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst 97:846–853CrossRefPubMed
19.
Zurück zum Zitat Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H et al (2000) Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 343:162–168CrossRefPubMed Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H et al (2000) Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 343:162–168CrossRefPubMed
20.
Zurück zum Zitat Dean CB, Nielsen JD (2007) Generalized linear mixed models: a review and some extensions. Lifetime Data Anal 13:497–512CrossRefPubMed Dean CB, Nielsen JD (2007) Generalized linear mixed models: a review and some extensions. Lifetime Data Anal 13:497–512CrossRefPubMed
21.
Zurück zum Zitat Steyerberg EW, Eijkemans MJ, Harrell FE Jr, Habbema JD (2000) Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med 19:1059–1079CrossRefPubMed Steyerberg EW, Eijkemans MJ, Harrell FE Jr, Habbema JD (2000) Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med 19:1059–1079CrossRefPubMed
22.
Zurück zum Zitat Wang D, Zhang W, Bakhai A (2004) Comparison of Bayesian model averaging and stepwise methods for model selection in logistic regression. Stat Med 23:3451–3467CrossRefPubMed Wang D, Zhang W, Bakhai A (2004) Comparison of Bayesian model averaging and stepwise methods for model selection in logistic regression. Stat Med 23:3451–3467CrossRefPubMed
23.
24.
Zurück zum Zitat Park MY, Hastie T (2007) L1-regularization path algorithm for generalized linear models. J R Stat Soc Ser B Stat Methodol 69:659–677CrossRef Park MY, Hastie T (2007) L1-regularization path algorithm for generalized linear models. J R Stat Soc Ser B Stat Methodol 69:659–677CrossRef
25.
Zurück zum Zitat Volinsky CT, Madigan D, Raftery AE, Kronmal RA (1977) Bayesian model averaging in proportional hazard models: assessing the risk of a stroke. J R Stat Soc Ser C Appl Stat 46:433–448CrossRef Volinsky CT, Madigan D, Raftery AE, Kronmal RA (1977) Bayesian model averaging in proportional hazard models: assessing the risk of a stroke. J R Stat Soc Ser C Appl Stat 46:433–448CrossRef
26.
Zurück zum Zitat Hosmer D, Lemeshow S (2000) Applied logistic regression. Wiley, New YorkCrossRef Hosmer D, Lemeshow S (2000) Applied logistic regression. Wiley, New YorkCrossRef
27.
Zurück zum Zitat Vermont J, Bosson JL, François P, Robert C, Rueff A et al (1991) Strategies for graphical threshold determination. Comput Methods Programs Biomed 35:141–150CrossRefPubMed Vermont J, Bosson JL, François P, Robert C, Rueff A et al (1991) Strategies for graphical threshold determination. Comput Methods Programs Biomed 35:141–150CrossRefPubMed
28.
Zurück zum Zitat Schäfer H (1989) Constructing a cut-off point for a quantitative diagnostic test. Stat Med 8:1381–1391CrossRefPubMed Schäfer H (1989) Constructing a cut-off point for a quantitative diagnostic test. Stat Med 8:1381–1391CrossRefPubMed
29.
Zurück zum Zitat Gallop RJ, Crits-Christoph P, Muenz LR, Tu XM (2003) Determination and interpretation of the optimal operating point for ROC curves derived through generalized linear models. Underst Stat 2:219–242CrossRef Gallop RJ, Crits-Christoph P, Muenz LR, Tu XM (2003) Determination and interpretation of the optimal operating point for ROC curves derived through generalized linear models. Underst Stat 2:219–242CrossRef
30.
Zurück zum Zitat Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157–172CrossRefPubMed Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157–172CrossRefPubMed
31.
Zurück zum Zitat Seo JY, Chun J, Lee C, Hong KS, Im JP et al (2015) Novel risk stratification for recurrence after endoscopic resection of advanced colorectal adenoma. Gastrointest Endosc 81:655–664CrossRefPubMed Seo JY, Chun J, Lee C, Hong KS, Im JP et al (2015) Novel risk stratification for recurrence after endoscopic resection of advanced colorectal adenoma. Gastrointest Endosc 81:655–664CrossRefPubMed
32.
Zurück zum Zitat Fairley KJ, Li J, Komar M, Steigerwalt N, Erlich P (2014) Predicting the risk of recurrent adenoma and incident colorectal cancer based on findings of the baseline colonoscopy. Clin Transl Gastroenterol 5:e64CrossRefPubMedPubMedCentral Fairley KJ, Li J, Komar M, Steigerwalt N, Erlich P (2014) Predicting the risk of recurrent adenoma and incident colorectal cancer based on findings of the baseline colonoscopy. Clin Transl Gastroenterol 5:e64CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat van Enckevort CC, de Graaf AP, Hollema H, Sluiter WJ, Kleibeuker JH et al (2014) Predictors of colorectal neoplasia after polypectomy: based on initial and consecutive findings. Neth J Med 72:139–145PubMed van Enckevort CC, de Graaf AP, Hollema H, Sluiter WJ, Kleibeuker JH et al (2014) Predictors of colorectal neoplasia after polypectomy: based on initial and consecutive findings. Neth J Med 72:139–145PubMed
34.
Zurück zum Zitat Jang ES, Kim JW, Jung YJ, Jeong JB, Kim BG et al (2013) Clinical and endoscopic predictors of colorectal adenoma recurrence after colon polypectomy. Turk J Gastroenterol 24:476–482CrossRefPubMed Jang ES, Kim JW, Jung YJ, Jeong JB, Kim BG et al (2013) Clinical and endoscopic predictors of colorectal adenoma recurrence after colon polypectomy. Turk J Gastroenterol 24:476–482CrossRefPubMed
35.
Zurück zum Zitat Brenner H, Chang-Claude J, Jansen L, Seiler CM, Hoffmeister M (2012) Role of colonoscopy and polyp characteristics in colorectal cancer after colonoscopic polyp detection: a population-based case–control study. Ann Intern Med 157:225–232CrossRefPubMed Brenner H, Chang-Claude J, Jansen L, Seiler CM, Hoffmeister M (2012) Role of colonoscopy and polyp characteristics in colorectal cancer after colonoscopic polyp detection: a population-based case–control study. Ann Intern Med 157:225–232CrossRefPubMed
36.
Zurück zum Zitat Cottet V, Jooste V, Fournel I, Bouvier AM, Faivre J et al (2012) Long-term risk of colorectal cancer after adenoma removal: a population-based cohort study. Gut 61:1180–1186CrossRefPubMed Cottet V, Jooste V, Fournel I, Bouvier AM, Faivre J et al (2012) Long-term risk of colorectal cancer after adenoma removal: a population-based cohort study. Gut 61:1180–1186CrossRefPubMed
37.
Zurück zum Zitat de Jonge V, Sint Nicolaas J, van Leerdam ME, Kuipers EJ, Veldhuyzen van Zanten SJ (2011) Systematic literature review and pooled analyses of risk factors for finding adenomas at surveillance colonoscopy. Endoscopy 43:560–572CrossRefPubMed de Jonge V, Sint Nicolaas J, van Leerdam ME, Kuipers EJ, Veldhuyzen van Zanten SJ (2011) Systematic literature review and pooled analyses of risk factors for finding adenomas at surveillance colonoscopy. Endoscopy 43:560–572CrossRefPubMed
38.
Zurück zum Zitat Nusko G, Hahn EG, Mansmann U (2008) Risk of advanced metachronous colorectal adenoma during long-term follow-up. Int J Colorectal Dis 23:1065–1071CrossRefPubMed Nusko G, Hahn EG, Mansmann U (2008) Risk of advanced metachronous colorectal adenoma during long-term follow-up. Int J Colorectal Dis 23:1065–1071CrossRefPubMed
39.
Zurück zum Zitat Bonithon-Kopp C, Piard F, Fenger C, Cabeza E, O’Morain C et al (2004) Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum 47:323–333CrossRefPubMed Bonithon-Kopp C, Piard F, Fenger C, Cabeza E, O’Morain C et al (2004) Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum 47:323–333CrossRefPubMed
40.
Zurück zum Zitat Bertario L, Russo A, Sala P, Pizzetti P, Ballardini G et al (2003) Predictors of metachronous colorectal neoplasms in sporadic adenoma patients. Int J Cancer 105:82–87CrossRefPubMed Bertario L, Russo A, Sala P, Pizzetti P, Ballardini G et al (2003) Predictors of metachronous colorectal neoplasms in sporadic adenoma patients. Int J Cancer 105:82–87CrossRefPubMed
42.
Zurück zum Zitat Gschwantler M, Kriwanek S, Langner E, Goritzer B, Schrutka-Kolbl C et al (2002) High-grade dysplasia and invasive carcinoma in colorectal adenomas: a multivariate analysis of the impact of adenoma and patient characteristics. Eur J Gastroenterol Hepatol 14:183–188CrossRefPubMed Gschwantler M, Kriwanek S, Langner E, Goritzer B, Schrutka-Kolbl C et al (2002) High-grade dysplasia and invasive carcinoma in colorectal adenomas: a multivariate analysis of the impact of adenoma and patient characteristics. Eur J Gastroenterol Hepatol 14:183–188CrossRefPubMed
43.
Zurück zum Zitat Bertario L, Russo A, Sala P, Pizzetti P, Ballardini G et al (1999) Risk of colorectal cancer following colonoscopic polypectomy. Tumori 85:157–162PubMed Bertario L, Russo A, Sala P, Pizzetti P, Ballardini G et al (1999) Risk of colorectal cancer following colonoscopic polypectomy. Tumori 85:157–162PubMed
44.
Zurück zum Zitat Yang G, Zheng W, Sun QR, Shu XO, Li WD et al (1998) Pathologic features of initial adenomas as predictors for metachronous adenomas of the rectum. J Natl Cancer Inst 90:1661–1665CrossRefPubMed Yang G, Zheng W, Sun QR, Shu XO, Li WD et al (1998) Pathologic features of initial adenomas as predictors for metachronous adenomas of the rectum. J Natl Cancer Inst 90:1661–1665CrossRefPubMed
45.
Zurück zum Zitat Triantafyllou K, Papatheodoridis GV, Paspatis GA, Vasilakaki TH, Elemenoglou I et al (1997) Predictors of the early development of advanced metachronous colon adenomas. Hepatogastroenterology 44:533–538PubMed Triantafyllou K, Papatheodoridis GV, Paspatis GA, Vasilakaki TH, Elemenoglou I et al (1997) Predictors of the early development of advanced metachronous colon adenomas. Hepatogastroenterology 44:533–538PubMed
46.
Zurück zum Zitat Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK et al (2014) Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 370:1298–1306CrossRefPubMedPubMedCentral Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK et al (2014) Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 370:1298–1306CrossRefPubMedPubMedCentral
47.
Zurück zum Zitat Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U et al (2010) Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 362:1795–1803CrossRefPubMed Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U et al (2010) Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 362:1795–1803CrossRefPubMed
49.
Zurück zum Zitat Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P et al (2014) Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 370:1287–1297CrossRefPubMed Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P et al (2014) Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 370:1287–1297CrossRefPubMed
Metadaten
Titel
A prognostic model for advanced colorectal neoplasia recurrence
verfasst von
Lin Liu
Karen Messer
John A. Baron
David A. Lieberman
Elizabeth T. Jacobs
Amanda J. Cross
Gwen Murphy
Maria Elena Martinez
Samir Gupta
Publikationsdatum
12.08.2016
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 10/2016
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-016-0795-5

Weitere Artikel der Ausgabe 10/2016

Cancer Causes & Control 10/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.